☰

Panagiotis Papageorgis, Ph.D. - Publications

Affiliations: 
2009 Boston University, Boston, MA, United States 
Area:
Genetics, Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Tamamouna V, Pavlou E, Neophytou CM, Papageorgis P, Costeas P. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention. International Journal of Molecular Sciences. 23. PMID 36430404 DOI: 10.3390/ijms232213931  0.425
2022 Panagi M, Mpekris F, Chen P, Voutouri C, Nakagawa Y, Martin JD, Hiroi T, Hashimoto H, Demetriou P, Pierides C, Samuel R, Stylianou A, Michael C, Fukushima S, Georgiou P, ... Papageorgis P, et al. Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models. Nature Communications. 13: 7165. PMID 36418896 DOI: 10.1038/s41467-022-34744-1  0.378
2022 Christodoulou P, Boutsikos P, Neophytou CM, Kyriakou TC, Christodoulou MI, Papageorgis P, Stephanou A, Patrikios I. Amygdalin as a chemoprotective agent in co-treatment with cisplatin. Frontiers in Pharmacology. 13: 1013692. PMID 36204233 DOI: 10.3389/fphar.2022.1013692  0.374
2021 Demetriadou C, Raoukka A, Charidemou E, Mylonas C, Michael C, Parekh S, Koufaris C, Skourides P, Papageorgis P, Tessarz P, Kirmizis A. Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance. Oncogene. PMID 34785778 DOI: 10.1038/s41388-021-02113-9  0.312
2021 Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers. 13. PMID 34503172 DOI: 10.3390/cancers13174363  0.389
2021 Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities. Cancers. 13. PMID 33922795 DOI: 10.3390/cancers13092053  0.412
2021 Mpekris F, Panagi M, Voutouri C, Martin JD, Samuel R, Takahashi S, Gotohda N, Suzuki T, Papageorgis P, Demetriou P, Pierides C, Koumas L, Costeas P, Kojima M, Ishii G, et al. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2001917. PMID 33552852 DOI: 10.1002/advs.202001917  0.385
2020 Neophytou CM, Pierides C, Christodoulou MI, Costeas P, Kyriakou TC, Papageorgis P. The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy. Frontiers in Oncology. 10: 899. PMID 32656079 DOI: 10.3389/Fonc.2020.00899  0.451
2020 Thrasyvoulou S, Vartholomatos G, Markopoulos G, Noutsopoulos D, Mantziou S, Gkartziou F, Papageorgis P, Charchanti A, Kouklis P, Constantinou AI, Tzavaras T. VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells. Oncology Reports. PMID 32377731 DOI: 10.3892/Or.2020.7596  0.451
2020 Panagi M, Voutouri C, Mpekris F, Papageorgis P, Martin MR, Martin JD, Demetriou P, Pierides C, Polydorou C, Stylianou A, Louca M, Koumas L, Costeas P, Kataoka K, Cabral H, et al. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity. Theranostics. 10: 1910-1922. PMID 32042344 DOI: 10.7150/Thno.36936  0.399
2020 Wong CK, Lambert AW, Ozturk S, Papageorgis P, Lopez D, Shen N, Sen Z, Abdolmaleky HM, Győrffy B, Feng H, Thiagalingam S. Targeting RICTOR sensitizes SMAD4-negative colon cancer to irinotecan. Molecular Cancer Research : McR. PMID 31932471 DOI: 10.1158/1541-7786.Mcr-19-0525  0.794
2019 Neophytou CM, Kyriakou TC, Papageorgis P. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy. International Journal of Molecular Sciences. 20. PMID 31817646 DOI: 10.3390/Ijms20246158  0.512
2019 Gkretsi V, Kalli M, Efstathiades C, Papageorgis P, Papanikolaou V, Zacharia LC, Tsezou A, Athanassiou E, Stylianopoulos T. Depletion of Ras Suppressor-1 (RSU-1) promotes cell invasion of breast cancer cells through a compensatory upregulation of a truncated isoform. Scientific Reports. 9: 10050. PMID 31296919 DOI: 10.1038/S41598-019-46575-0  0.429
2019 Martin JD, Panagi M, Wang C, Khan TT, Martin MR, Voutouri C, Toh K, Papageorgis P, Mpekris F, Polydorou C, Ishii G, Takahashi S, Gotohda N, Suzuki T, Wilhelm ME, et al. Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. Acs Nano. PMID 31187975 DOI: 10.1021/Acsnano.8B07865  0.428
2019 Wong CK, Gromisch C, Ozturk S, Papageorgis P, Abdolmaleky HM, Reinhard BM, Thiagalingam A, Thiagalingam S. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer. Cancer Biology & Therapy. 1-8. PMID 30922194 DOI: 10.1080/15384047.2019.1595285  0.765
2019 Demetriadou C, Pavlou D, Mpekris F, Achilleos C, Stylianopoulos T, Zaravinos A, Papageorgis P, Kirmizis A. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression. Cell Death & Disease. 10: 236. PMID 30858358 DOI: 10.1038/S41419-019-1487-3  0.414
2019 Kalli M, Mpekris F, Wong CK, Panagi M, Ozturk S, Thiagalingam S, Stylianopoulos T, Papageorgis P. Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis. Frontiers in Oncology. 9: 32. PMID 30805303 DOI: 10.3389/Fonc.2019.00032  0.813
2018 Neophytou C, Boutsikos P, Papageorgis P. Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis. Frontiers in Oncology. 8: 31. PMID 29520340 DOI: 10.3389/Fonc.2018.00031  0.501
2018 Kalli M, Papageorgis P, Gkretsi V, Stylianopoulos T. Solid Stress Facilitates Fibroblasts Activation to Promote Pancreatic Cancer Cell Migration. Annals of Biomedical Engineering. PMID 29470747 DOI: 10.1007/S10439-018-1997-7  0.446
2018 Mpekris F, Voutouri C, Papageorgis P, Stylianopoulos T. Stress alleviation strategy in cancer treatment: Insights from a mathematical model Zamm - Journal of Applied Mathematics and Mechanics / Zeitschrift FüR Angewandte Mathematik Und Mechanik. 98: 2295-2306. DOI: 10.1002/Zamm.201700270  0.333
2017 Papageorgis P. Complex Interplay Between Aging and Cancer: Role of TGF-β Signaling. Critical Reviews in Oncogenesis. 22: 313-321. PMID 29604907 DOI: 10.1615/Critrevoncog.2017025134  0.437
2017 Mpekris F, Papageorgis P, Polydorou C, Voutouri C, Kalli M, Pirentis AP, Stylianopoulos T. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28662901 DOI: 10.1016/J.Jconrel.2017.06.022  0.491
2017 Polydorou C, Mpekris F, Papageorgis P, Voutouri C, Stylianopoulos T. Pirfenidone normalizes the tumor microenvironment to improve chemotherapy. Oncotarget. 8: 24506-24517. PMID 28445938 DOI: 10.18632/Oncotarget.15534  0.358
2017 Papageorgis P, Polydorou C, Mpekris F, Voutouri C, Agathokleous E, Kapnissi-Christodoulou CP, Stylianopoulos T. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner. Scientific Reports. 7: 46140. PMID 28393881 DOI: 10.1038/Srep46140  0.349
2017 Voutouri C, Polydorou C, Papageorgis P, Stylianopoulos T. Abstract A60: Hyaluronan and cancer cell derived swelling of solid tumors and implications for cancer therapy Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-A60  0.393
2016 Voutouri C, Polydorou C, Papageorgis P, Gkretsi V, Stylianopoulos T. Hyaluronan-Derived Swelling of Solid Tumors, the Contribution of Collagen and Cancer Cells, and Implications for Cancer Therapy. Neoplasia (New York, N.Y.). 18: 732-741. PMID 27886639 DOI: 10.1016/J.Neo.2016.10.001  0.39
2016 Ozturk S, Papageorgis P, Wong CK, Lambert AW, Abdolmaleky HM, Thiagalingam A, Cohen HT, Thiagalingam S. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 26739564 DOI: 10.1073/Pnas.1514663113  0.806
2015 Gkretsi V, Stylianou A, Papageorgis P, Polydorou C, Stylianopoulos T. Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy. Frontiers in Oncology. 5: 214. PMID 26528429 DOI: 10.3389/Fonc.2015.00214  0.366
2015 Lambert AW, Wong CK, Ozturk S, Papageorgis P, Raghunathan R, Alekseyev Y, Gower AC, Reinhard BM, Abdolmaleky HM, Thiagalingam S. Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells. Molecular Cancer Research : McR. PMID 26507575 DOI: 10.1158/1541-7786.Mcr-15-0079  0.796
2015 Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis. Breast Cancer Research : Bcr. 17: 98. PMID 26208975 DOI: 10.1186/S13058-015-0607-Y  0.793
2015 Papageorgis P. TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis. Journal of Oncology. 2015: 587193. PMID 25883652 DOI: 10.1155/2015/587193  0.502
2015 Papageorgis P, Stylianopoulos T. Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review). International Journal of Oncology. 46: 933-43. PMID 25573346 DOI: 10.3892/Ijo.2015.2816  0.429
2015 Papageorgis P, Ozturk S, Lambert AW, Neophytou CM, Tzatsos A, Wong CK, Thiagalingam S, Constantinou AI. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis Breast Cancer Research. 17. DOI: 10.1186/s13058-015-0607-y  0.778
2014 Voutouri C, Mpekris F, Papageorgis P, Odysseos AD, Stylianopoulos T. Role of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumors. Plos One. 9: e104717. PMID 25111061 DOI: 10.1371/Journal.Pone.0104717  0.359
2014 Neophytou CM, Constantinou C, Papageorgis P, Constantinou AI. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells Biochemical Pharmacology. 89: 31-42. PMID 24560876 DOI: 10.1016/J.Bcp.2014.02.003  0.493
2013 Pitta CA, Papageorgis P, Charalambous C, Constantinou AI. Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. Cancer Letters. 337: 167-76. PMID 23752064 DOI: 10.1016/J.Canlet.2013.05.031  0.381
2011 Abdolmaleky HM, Yaqubi S, Papageorgis P, Lambert AW, Ozturk S, Sivaraman V, Thiagalingam S. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophrenia Research. 129: 183-90. PMID 21550210 DOI: 10.1016/J.Schres.2011.04.007  0.724
2011 Papageorgis P, Cheng K, Ozturk S, Gong Y, Lambert AW, Abdolmaleky HM, Zhou JR, Thiagalingam S. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Research. 71: 998-1008. PMID 21245094 DOI: 10.1158/0008-5472.Can-09-3269  0.785
2010 Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Research. 70: 968-78. PMID 20086175 DOI: 10.1158/0008-5472.Can-09-1872  0.794
2010 Thiagalingam S, Lambert AW, Ozturk S, Abdolmaleky HM, Papageorgis P. Abstract 187: Epigenetic memory during breast cancer progression is sustained by Smad signaling pathway Cancer Research. 70: 187-187. DOI: 10.1158/1538-7445.Am10-187  0.801
2009 Gao F, Ponte JF, Levy M, Papageorgis P, Cook NM, Ozturk S, Lambert AW, Thiagalingam A, Abdolmaleky HM, Sullivan BA, Thiagalingam S. hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation. Cancer Biology & Therapy. 8: 548-56. PMID 19252416 DOI: 10.4161/Cbt.8.7.7929  0.775
2009 Gao F, Ponte JF, Papageorgis P, Levy M, Ozturk S, Lambert AW, Pan H, Chinnappan D, Cheng KH, Thiagalingam A, Abdolmaleky HM, Thiagalingam S. hBub1 deficiency triggers a novel p53 mediated early apoptotic checkpoint pathway in mitotic spindle damaged cells. Cancer Biology & Therapy. 8: 627-35. PMID 19242126 DOI: 10.4161/Cbt.8.7.7928  0.729
2007 Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S. Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biology & Therapy. 6: 1638-43. PMID 18245958 DOI: 10.4161/Cbt.6.10.4904  0.756
2006 Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics. 15: 3132-45. PMID 16984965 DOI: 10.1093/Hmg/Ddl253  0.734
Show low-probability matches.